This will make the initial units unattractive for most clinical labs but, as the price comes down, will ultimately make automated PCR diagnostics practical. This concludes my discussion on PCR-based diagnostics. I hope I have provided you with a general overview of the advantages of PCR-based assays, have given you some insight into the current state of the technology, and have addressed some of the issues which are slowing the process of incorporation of this technology into the clinical lab setting. Within the constraints of this column, it is impossible for me to address every issue regarding PCR-based diagnostics. Every type of diagnostic tool has its pros and cons, and most have an important role in diagnostics.
None are foolproof.
Any diagnosis should be confirmed by a second, independent method. PCR has a place as either the primary diagnostic tool, or as a means of confirmation. It is an excellent technology, and deserves to be moved from the research to the clinical setting. Investigen Inc. He is currently involved in research for the development of rapid molecular diagnostics predominately in, but not limited to, the field of clinical pathogens. By using this website you agree to the terms and conditions disclosed on our Legal Terms page.